No profile data available.
Ocean Biomedical, Inc. (OCEA) is a healthcare company in the additional cancer treatment drugs industry, based in Providence, United States, with about 7 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$9.48 million. In Q1 2025 (the quarter ended March 31, 2025) revenue was $0. Its market capitalization was $232,365 as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.
Ocean Biomedical reported $0 in revenue for fiscal year 2024. In Q1 2025 revenue was $0.
$232,365 as of December 4, 2025.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Carisma Therapeutics, Inc. (CARM), Curis, Inc. (CRIS), Marijuana Inc. (MAJI), Regen BioPharma, Inc. (RGBP).